Min Xiao

Rare cell variability and drug-induced reprogramming as a mode of cancer drug resistance

Sydney M. Shaffer, Margaret C. Dunagin, Stefan Torborg et al. · Nature · 2017 · 1.3K citations

Medicine, Cancer Biology, Oncology +16

Enhancing CD8+ T Cell Fatty Acid Catabolism within a Metabolically Challenging Tumor Microenvironment Increases the Efficacy of Melanoma Immunotherapy

Ying Zhang, Raj K. Kurupati, Ling Liu et al. · Cancer Cell · 2017 · 605 citations · Full text

Medicine, Immunology, Oncology +14

Targeting mitochondrial biogenesis to overcome drug resistance to MAPK inhibitors

Gao Zhang, Dennie T. Frederick, Lawrence W. Wu et al. · Journal of Clinical Investigation · 2016 · 299 citations · Full text

Life Sciences, Cancer Biology, Oncology +16

Increased cyclin D1 expression can mediate BRAF inhibitor resistance in <i>BRAF</i> V600E–mutated melanomas

Keiran S.M. Smalley, Mercedes Lioni, Maurizia Dalla Palma et al. · Molecular Cancer Therapeutics · 2008 · 293 citations · Full text

Medicine, Molecular Biology, Oncology +17

Notch1 Signaling Promotes Primary Melanoma Progression by Activating Mitogen-Activated Protein Kinase/Phosphatidylinositol 3-Kinase-Akt Pathways and Up-regulating N-Cadherin Expression

Zhaojun Liu, Min Xiao, Klara Balint et al. · Cancer Research · 2006 · 272 citations

Life Sciences, Cell Biology, Oncology +16